redemption and termination AgreementRedemption and Termination Agreement • January 26th, 2024 • NeuBase Therapeutics, Inc. • Pharmaceutical preparations • New York
This Redemption and Termination Agreement (this “Agreement”) is dated as of January 26, 2024, by and between NeuBase Therapeutics, Inc. or any Successor Entity thereto (together, the “Company”) and Armistice Capital Master Fund Ltd. (the “Warrant Holder”). Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Securities Purchase Agreements (as defined below).
